Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

As South Africans continue to experience the winter chill, the National Institute for Communicable Diseases ( NICD is urging ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

At 21 months old, Olivia is bright, bubbly, and full of joy. But instead of running around like other toddlers, she’s spent ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

The RSV vaccination eligibility age has been lowered from 60 years to 50 years according to an update on the CDC website.

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...